Interestingly, phosphorylation at S83 and S163 by PFTK1 inhibits physical interaction of transgelin-2 to actin, which results in enhanced HCC cell motility (Leung et al., 2011). The gene discussed is TAGLN2; the disease is hepatocellular carcinoma.